Sumitomo Mitsui DS Asset Management Company Ltd Has $1.96 Million Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 5.9% in the third quarter, according to the company in its most recent filing with the SEC. The fund owned 48,043 shares of the real estate investment trust’s stock after buying an additional 2,688 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Omega Healthcare Investors were worth $1,955,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. UMB Bank n.a. increased its position in Omega Healthcare Investors by 353.4% during the 3rd quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 516 shares during the period. Versant Capital Management Inc acquired a new stake in Omega Healthcare Investors in the 2nd quarter worth about $26,000. WFA Asset Management Corp acquired a new stake in Omega Healthcare Investors in the 1st quarter worth about $39,000. Covestor Ltd boosted its holdings in Omega Healthcare Investors by 47.6% in the 1st quarter. Covestor Ltd now owns 1,337 shares of the real estate investment trust’s stock valued at $42,000 after purchasing an additional 431 shares during the period. Finally, Highlander Capital Management LLC grew its position in shares of Omega Healthcare Investors by 52.0% during the 1st quarter. Highlander Capital Management LLC now owns 1,900 shares of the real estate investment trust’s stock worth $60,000 after purchasing an additional 650 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Insider Activity at Omega Healthcare Investors

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the business’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.37% of the stock is owned by company insiders.

Omega Healthcare Investors Price Performance

Shares of NYSE:OHI opened at $41.32 on Tuesday. The firm has a 50 day simple moving average of $39.78 and a 200 day simple moving average of $35.36. The company has a market cap of $10.21 billion, a price-to-earnings ratio of 37.23, a PEG ratio of 1.29 and a beta of 1.00. Omega Healthcare Investors, Inc. has a one year low of $27.53 and a one year high of $41.73. The company has a debt-to-equity ratio of 1.19, a current ratio of 5.79 and a quick ratio of 5.79.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.65 by ($0.20). Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The firm had revenue of $252.70 million for the quarter, compared to analyst estimates of $205.92 million. During the same period last year, the business earned $0.74 EPS. The company’s revenue was up 17.5% compared to the same quarter last year. Research analysts predict that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Monday, August 5th were paid a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 6.49%. The ex-dividend date was Monday, August 5th. Omega Healthcare Investors’s dividend payout ratio is currently 241.44%.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on OHI shares. Mizuho cut Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and boosted their price target for the company from $34.00 to $35.00 in a research note on Thursday, July 25th. BMO Capital Markets upped their target price on Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research report on Monday, October 7th. Berenberg Bank initiated coverage on Omega Healthcare Investors in a research note on Friday. They issued a “buy” rating and a $45.00 price target for the company. Truist Financial increased their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research note on Wednesday, September 4th. Finally, Wells Fargo & Company restated an “overweight” rating and issued a $43.00 target price (up from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Eight analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $37.80.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.